Search

everythinglearnresearchcommunity

for

Search:↓

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

88% phenol is effective for treating alopecia areata.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

A man with rare Lichen Planopilaris lost body hair, not scalp hair, and treatment stopped itching but didn't regrow hair.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Experts don't fully agree on how to diagnose certain hair growth disorders and more research is needed to understand them better.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Stopping the use of fluocinolone oil containing balsam fragrance improved hair regrowth in children allergic to it.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.